Comparison of interleukin-22 and interleukin-10 soluble receptor complexes
about
A model of the ternary complex of interleukin-10 with its soluble receptors.Structure of IL-22 bound to its high-affinity IL-22R1 chainInterleukin-22 Signaling in the Regulation of Intestinal Health and DiseaseNew advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseasesCrystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanismStructure and Mechanism of Receptor Sharing by the IL-10R2 Common ChainInterleukin 22 attenuated angiotensin II induced acute lung injury through inhibiting the apoptosis of pulmonary microvascular endothelial cellsThe role of macrophage IL-10/innate IFN interplay during virus-induced asthma.Interleukin-22: immunobiology and pathology.The molecular basis of IL-10 function: from receptor structure to the onset of signaling.Identification and characterization of a +1 frameshift observed during the expression of Epstein-Barr virus IL-10 in Escherichia coli.Epstein-Barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling propertiesInterleukin-22 forms dimers that are recognized by two interleukin-22R1 receptor chains.Differential Requirements for IL-17A and IL-22 in Cecal versus Colonic Inflammation Induced by Helicobacter hepaticus.Crystallization and preliminary X-ray diffraction analysis of human IL-22 bound to the extracellular IL-22R1 chain.Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy.Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus.Therapeutic opportunities of the IL-22-IL-22R1 system.How Does Interleukin-22 Mediate Liver Regeneration and Prevent Injury and Fibrosis?Cytokines IL-17 and IL-22 in the host response to infection.Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.Genetic variant of IL-10RA and susceptibility to rheumatoid arthritis in a Chinese population.The N-glycan on Asn54 affects the atypical N-glycan composition of plant-produced interleukin-22, but does not influence its activity.Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex.Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid.A novel, dual cytokine-secretion assay for the purification of human Th22 cells that do not co-produce IL-17A.Is there an interaction between interleukin-10 and interleukin-22?IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis.Does angiotensin II modulate erythropoietin production in HepG2 cells?Pivotal Role of IL-22 Binding Protein in the Epithelial Autoregulation of Interleukin-22 Signaling in the Control of Skin Inflammation.
P2860
Q24530097-38EDA89A-ACFE-4ECE-A439-A3F278B28B40Q24656543-AAE90333-77F1-4AD6-A6A2-C1C388090A9EQ26770224-08F9A068-094B-41DF-A5B3-77F9521A45E3Q27026399-7352364E-099B-46ED-9278-A3DEA61857A2Q27651398-688A28C6-7A0B-441F-B4A3-1780A9661B54Q27661538-40A750FB-528D-42D3-BBF4-3C971DA7C2C6Q33708468-DA549FA3-84D3-47A0-B0F7-C286B1E5D0C1Q35046046-A79B011A-44D3-414B-BCC0-D7B43C6B00DBQ35530956-0C478065-41C6-4EC3-B896-641DFF66214BQ35810601-1D823C60-E8C8-42CA-82FE-F9535815D4DDQ35875016-E9088F8F-E618-43B0-B222-2E5EAAF5446AQ36137341-7B66FF75-CCE3-481F-8713-110FDDBE2B25Q36459059-74EF0FAA-5ACA-4582-A0B1-4EF0EA349CEEQ36509083-F4E9CBF1-4626-4AD6-A529-15BB2E884776Q36640820-850B4596-48A7-4916-BE08-660C71B14A15Q37964608-1AEE156A-B5F9-4E3E-A4D0-2CCFE5FF8247Q38109528-BD0896B6-F88D-4441-9FB4-3BE7C527CC9FQ38174792-B7124560-D2D7-416D-85C6-5E6A2A342B5EQ38775072-3B790EFA-2116-43FB-87FE-D9964C8D963DQ39028574-A0A324C6-5978-4DE6-B498-1A925EC9467EQ39649359-EE548C34-A2C4-4A59-B0B5-056E4DE28A3BQ40504088-88364247-12CF-4CFD-BB29-76B7C14D37DBQ40852964-2E5B5728-9360-482C-A996-3A006618F97AQ42598575-EAAD9A56-2861-4D74-B507-AAAE1E0593A9Q43102028-4A3AA2DC-84CD-4F6D-A91C-C0E46C8DE98FQ48130689-7617B0AC-41DB-406D-8090-6A6FBAE51876Q52941837-C55D4806-50D4-4F6A-A874-B6351FC459FBQ53360318-7BBADC8C-C7F8-4789-AD9D-A471CFAB36E6Q54687081-9C4C4A92-E672-40D4-A374-937CBAF3CC6FQ55445913-F030E5A4-8E22-4A9D-8674-A8631BB98FE0
P2860
Comparison of interleukin-22 and interleukin-10 soluble receptor complexes
description
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im November 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/11/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/11/01)
@nl
наукова стаття, опублікована в листопаді 2002
@uk
مقالة علمية (نشرت في نوفمبر 2002)
@ar
name
Comparison of interleukin-22 and interleukin-10 soluble receptor complexes
@ast
Comparison of interleukin-22 and interleukin-10 soluble receptor complexes
@en
Comparison of interleukin-22 and interleukin-10 soluble receptor complexes
@nl
type
label
Comparison of interleukin-22 and interleukin-10 soluble receptor complexes
@ast
Comparison of interleukin-22 and interleukin-10 soluble receptor complexes
@en
Comparison of interleukin-22 and interleukin-10 soluble receptor complexes
@nl
prefLabel
Comparison of interleukin-22 and interleukin-10 soluble receptor complexes
@ast
Comparison of interleukin-22 and interleukin-10 soluble receptor complexes
@en
Comparison of interleukin-22 and interleukin-10 soluble receptor complexes
@nl
P2093
P1476
Comparison of interleukin-22 and interleukin-10 soluble receptor complexes
@en
P2093
Brandi C. Jones
Jennifer Cook
Kristopher Josephson
Mark R. Walter
Naomi J. Logsdon
P304
P356
10.1089/10799900260442520
P577
2002-11-01T00:00:00Z